Form 4: Clene Inc. Director Sells Over 100K Shares

Clene Inc. director and 10% owner, Chidozie Ugwumba, reported selling 100,997 shares of common stock through SymBiosis II, LLC in late March 2026.

Summary

• Chidozie Ugwumba, a Director and 10% Owner of Clene Inc. (CLNN), reported the sale of common stock.
• A total of 100,997 shares were sold across three separate transactions by SymBiosis II, LLC, an entity indirectly owned by Mr. Ugwumba.
• On March 27, 2026, 17,470 shares were sold at a price of $4.75 per share.
• On March 30, 2026, 15,536 shares were sold at a price of $5.10 per share.
• On March 31, 2026, 67,991 shares were sold at a price of $4.88 per share.
• Following these transactions, SymBiosis II, LLC beneficially owns 431,094 shares of Clene Inc. common stock.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the significant insider selling by a director and 10% owner, which can erode investor confidence.

Negatives

• A director and 10% owner selling a significant portion of their stake (approximately 19% of their initial reported holdings) can be interpreted as a negative signal regarding the company's future prospects or current valuation.
• The sales occurred over three consecutive trading days, indicating a deliberate reduction in exposure.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider selling, particularly by a director and a 10% owner, can be a significant indicator for investors. While such sales can be for personal liquidity, a substantial reduction in holdings often prompts scrutiny regarding management's confidence in the company's near-term performance or valuation.

Related Party Transactions

• The reported sales were conducted indirectly by SymBiosis II, LLC, an entity through which the director, Chidozie Ugwumba, beneficially owns shares.

Stakeholder Impact

• Shareholders may interpret the insider selling as a lack of confidence from a key stakeholder, potentially leading to decreased investor sentiment and downward pressure on the stock price.

Key Dates

Recommendation

A director and 10% owner reducing their stake by nearly 20% through open market sales suggests a lack of confidence in the company's current valuation or future prospects. This significant insider selling warrants a 'sell' recommendation for investors, as it signals potential headwinds or a belief that the stock is overvalued.

Keywords

Clene Inc., CLNN, Form 4, insider trading, stock sale, director, 10% owner, Ugwumba Chidozie, SymBiosis II LLC